NEPRIKLAUSOMA TYRIMŲ LABORATORIJA, UAB - financials and debts

Company age: 27 y. 6 mo.

Update

NEPRIKLAUSOMA TYRIMŲ LABORATORIJA - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 940,455 1,180,353 1,227,643 1,648,527 1,465,806 1,542,806 1,637,216 1,909,488
Profit before tax 93,683 298,558 342,579 363,597 68,709 79,778 -75,778 79,816
Net profit 82,754 258,288 297,330 308,413 57,186 66,799 -75,778 65,761
Equity 296,014 556,354 853,684 1,162,097 1,219,283 1,286,082 910,304 976,065
Liabilities 89,080 121,840 129,820 112,992 153,249 176,041 200,718 220,408
Non-current assets 177,333 138,791 146,515 172,643 430,779 349,192 277,924 192,056
Current assets 218,644 539,403 836,989 1,102,446 941,753 1,112,931 833,098 1,004,417
Total assets 395,977 678,194 983,504 1,275,089 1,372,532 1,462,123 1,111,022 1,196,473
Taxes paid
STI taxes - - - - - 424,359 569,742 573,861
Social insurance contributions - - - - - 236,602 281,679 303,579
Financial indicators
Revenue change y/y +14.2% +25.5% +4.0% +34.3% -11.1% +5.3% +6.1% +16.6%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 20.9% 38.1% 30.2% 24.2% 4.2% 4.6% -6.8% 5.5%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 28.0% 46.4% 34.8% 26.5% 4.7% 5.2% -8.3% 6.7%
Profit margin Net profit margin. Shows the overall profitability of the company. 8.8% 21.9% 24.2% 18.7% 3.9% 4.3% -4.6% 3.4%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 10.0% 25.3% 27.9% 22.1% 4.7% 5.2% -4.6% 4.2%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.3 0.2 0.2 0.1 0.1 0.1 0.2 0.2
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 22,985 29,632 30,691 32,537 29,813 32,710 31,535 35,090

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

Sales revenue

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

NEPRIKLAUSOMA TYRIMŲ LABORATORIJA - Social security debts

From To Debt, €
2026-01-16 2026-01-20 101.70
2025-05-16 2025-05-28 37.09

NEPRIKLAUSOMA TYRIMŲ LABORATORIJA - VMI tax arrears

From To Overdue, €
2024-10-09 2024-10-09 10289.14

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
NEPRIKLAUSOMA TYRIMU LABORATORIJA, UAB (code 110824551) is a private limited liability company operating in other technical testing and analysis. In 2025, it generated revenue of €1.91M, up 16.6% year on year and 23.8% above the 2023 level. Net profit reached €65.8K in 2025, following a loss of €75.8K in 2024 and profit of €66.8K in 2023. The 2025 profit margin was 3.4%, indicating a return to positive earnings after the prior-year decline. The balance sheet strengthened moderately, with total assets of €1.20M, equity of €976.1K and liabilities of €220.4K. Equity accounted for 81.6% of assets, while debt-to-equity stood at 0.23. Profitability and efficiency remained solid, with ROE at 6.7%, ROA at 5.5% and asset turnover at 1.60x. Revenue per employee was €35.4K, while profit per employee was €1.2K.